Cellular Intelligence | Biotech & Life Sciences

FROM Lerer Hippeau

Portfolio company Cellular Intelligence acquired global rights to Novo Nordisk's clinical-stage Parkinson's cell therapy program, with Novo Nordisk making an equity investment.

MILESTONE·prnewswire.com+1

MAY 11, 2026

FROM Harpoon Ventures

Portfolio company Cellular Intelligence acquired Novo Nordisk's STEM-PD program and received a strategic investment from Novo Nordisk.

MILESTONE·cellularintelligence.com

MAY 11, 2026

FROM AMD Ventures

Strategic investment in Cellular Intelligence (formerly Somite.ai) following its $47M Series A led by Khosla Ventures.

INVESTMENT·cellularintelligence.com

AUG 2025

FROM SciFi VC

Participated in Cellular Intelligence's $47M Series A for AI-powered cell-signaling foundation models.

INVESTMENT·cellularintelligence.com

MAY 2025